Literature DB >> 35070792

Demographic, clinical, electrocardiographic and echocardiographic characteristics of patients hospitalized with COVID-19 and cardiac disease at a tertiary hospital, South Africa.

Ruchika Meel1, Sarah A Van Blydenstein2.   

Abstract

BACKGROUND: Coronavirus associated disease 2019 (COVID-19) is associated with higher morbidity and mortality in patients with cardiovascular disease. There is a paucity of data regarding COVID-19 and cardiac disease from Africa. We aimed to describe the demographic, clinical, electrocardiographic and echocardiographic characteristics of patients with COVID-19 and cardiac disease at a tertiary hospital in South Africa.
METHODS: This was a retrospective cross-sectional descriptive study (Aug 2020 to March 2021) of 200 patients with COVID-19 and confirmed cardiac disease, conducted at Chris Hani Baragwanath. Demographic, clinical, electrocardiographic and echocardiographic characteristics were systematically collected.
RESULTS: Majority (86%) of patients were Africans with mean age 56.4±15.6 years (57.5% females). Fifty three percent were unemployed and 28% were pensioners. Main comorbidities were hypertension (69.5%), diabetes mellitus (31.5%) and human immunodeficiency virus (HIV) (22.5%). Majority of the patients were overweight or obese (65.5%). All except 8 patients were on chronic medication. Dyspnoea on admission was noted in 88.5% of patients. Seventy nine percent of patients had abnormal chest X-Ray. Frequently documented electrocardiography findings were sinus tachycardia (63%) and atrial fibrillation, noted in 7% of patients. The most common indication for echocardiography was heart failure (30%). Severe left ventricular dysfunction was noted in 21.5%. Features of pulmonary hypertension were present in 45.5%. The right ventricle was enlarged in 59% of patients, and functional tricuspid regurgitation was noted in 54.5%. The most common diagnoses were hypertensive heart disease with preserved ejection fraction (35.8%), cardiomyopathies (20%), cor pulmonale (15.7%), acute coronary syndrome (6.5%), infective endocarditis (5.5%) and valvular heart disease (2.5%). Echocardiography modified management in 53% of cases. An in-hospital mortality of 17.5% was noted. On multivariate logistic regression analysis sinus tachycardia was the most important independent predictor of mortality (odds ratio, OR: 2.52, 95% confidence interval, CI: 1.08-5.85, P=0.03).
CONCLUSIONS: Most patients were obese females with underlying hypertension. Echocardiography altered management in about half the patients. Mortality amongst this cohort of patients was high and were predominantly males. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Africa; Coronavirus associated disease 2019 (COVID-19); echocardiography, cardiac disease

Year:  2021        PMID: 35070792      PMCID: PMC8748491          DOI: 10.21037/cdt-21-459

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  17 in total

1.  Global evaluation of echocardiography in patients with COVID-19.

Authors:  Marc R Dweck; Anda Bularga; Rebecca T Hahn; Rong Bing; Kuan Ken Lee; Andrew R Chapman; Audrey White; Giovanni Di Salvo; Leyla Elif Sade; Keith Pearce; David E Newby; Bogdan A Popescu; Erwan Donal; Bernard Cosyns; Thor Edvardsen; Nicholas L Mills; Kristina Haugaa
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-09-01       Impact factor: 6.875

2.  Tablet-Based Limited Echocardiography to Reduce Sonographer Scan and Decontamination Time during the COVID-19 Pandemic.

Authors:  Sean R McMahon; Garrett De Francis; Sara Schwartz; William L Duvall; Bhaskar Arora; David I Silverman
Journal:  J Am Soc Echocardiogr       Date:  2020-05-11       Impact factor: 5.251

3.  Bradycardia in Patients With COVID-19: A Calm Before the Storm?

Authors:  Eluwana A Amaratunga; Douglas S Corwin; Lynn Moran; Richard Snyder
Journal:  Cureus       Date:  2020-06-13

4.  Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States.

Authors:  Jae Hyung Cho; Ali Namazi; Richard Shelton; Archana Ramireddy; Ashkan Ehdaie; Michael Shehata; Xunzhang Wang; Eduardo Marbán; Sumeet S Chugh; Eugenio Cingolani
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

Review 5.  Cardiac Injury Biomarkers and the Risk of Death in Patients with COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Sami H Alzahrani; Mohammed W Al-Rabia
Journal:  Cardiol Res Pract       Date:  2021-03-18       Impact factor: 1.866

Review 6.  Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.

Authors:  Carmine Savoia; Massimo Volpe; Reinhold Kreutz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

7.  Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru.

Authors:  Fernando Mejía; Carlos Medina; Enrique Cornejo; Enrique Morello; Sergio Vásquez; Jorge Alave; Alvaro Schwalb; Germán Málaga
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

8.  Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy.

Authors:  Paolo Giorgi Rossi; Massimiliano Marino; Debora Formisano; Francesco Venturelli; Massimo Vicentini; Roberto Grilli
Journal:  PLoS One       Date:  2020-08-27       Impact factor: 3.240

9.  Focal myocarditis in a young male with SARS-CoV-2 infection.

Authors:  Ruchika Meel; Tyral D Ramsamy; Rajiv Narsing; Michelle Wong
Journal:  Oxf Med Case Reports       Date:  2021-02-15

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.